FXYD5通过EMT调节来调节胃癌细胞转移和耐药性
Yuning Mao1,2, Yaohua Hu1, Han Meng1
1Division of Cancer Biology, Laboratory Animal Center, Air Force Medical University, 710032, Xi'an, Shaanxi, China.
Cancer gene therapy
|February 21, 2025
概括
胃癌 (GC) 的进展和转移与升高的FXYD5水平有关. 减少FXYD5抑制了GC的传播,并逆转了化疗耐药性,将其确定为潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胃癌 (GC) 是全球癌症死亡的主要原因之一.
- 药物耐药性,复发和转移导致高的GC死亡率.
- 对于有效的GC治疗,迫切需要新的治疗点.
研究的目的:
- 确定胃癌 (GC) 的新型治疗点.
- 调查含有FXYD域的离子运输调节器5 (FXYD5) 在GC进展和转移中的作用.
- 评估FXYD5作为克服GC化学疗法耐药性的潜在目标.
主要方法:
- 通过 Orthotopic 移植建立患者衍生异种移植 (PDX) 的转移性胃癌模型.
- 使用PCR-array进行初级和转移性瘤之间的基因表达差异分析.
- 试验室内试验涉及FXYD5敲击,以评估其对GC细胞入侵,转移,增殖和耐药性的影响.
主要成果:
- 与原发性瘤相比,转移性GC瘤的FXYD5表达显著更高.
- 减少FXYD5表达抑制了GC细胞的入侵,转移和增殖.
- 沉默FXYD5通过调节上皮质-介质酶过渡 (EMT) 和多药耐药性蛋白2 (MRP2) 表达,逆转了对多克索鲁比辛和温克里斯的耐药性.
结论:
- FXYD5在胃癌的进展,入侵和转移中起着至关重要的作用.
- FXYD5参与调节GC中的化疗耐药性.
- FXYD5代表了对胃癌临床干预的有前途的新型治疗标.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.7K
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Chemotaxis and Direction of Cell Migration
3.3K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.3K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
